10 Publicly Traded Biotechs Utilizing AI-based Research Platforms
According to our intelligence report, The State of Artificial Intelligence (AI) in the Biopharma Industry, more than 450 life sciences …
All Posts
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …
Tech-First Companies Take the Lead in AI Drug Discovery
In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire …
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Eight Approaches to Leveraging AI in Clinical Trials with the Key Industry Innovators
In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety …
Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
Will Biologics Surpass Small Molecules In The Pharmaceutical Race?
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …
10 Companies Applying AI for Biologics Discovery
When we hear “AI in drug discovery”, there is a high chance our imagination would draw a small molecule discovery …
From Data to Treatment: Medidata's Fareed Melhem Discusses AI's Impact on Clinical Trials
As the potential of artificial intelligence (AI) continues to unfold, how is it revolutionizing the intricate landscape of clinical trials? …
10 Notable Companies Making Strides in Decentralized Clinical Trials
The world of clinical trials is undergoing an evolution as the rise of decentralized clinical trials (DCTs) brings about a change …
From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology
It is hard to overestimate the potential of biotechnology to address some of the most pressing challenges of the 21st …
Navigating Data Scarcity: AI's Emerging Role in Biotech
‘Garbage in, garbage out’ is a well-known principle in the machine learning (ML) community, and it is certainly true when …
